Qingdao Vland Biotech INC. (SHA:603739)
China flag China · Delayed Price · Currency is CNY
12.24
+0.39 (3.29%)
Nov 5, 2026, 3:00 PM CST

SHA:603739 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
70.9469.8162.6480.7169.84132.57
Depreciation & Amortization
115.65115.95110.9973.7965.7151.7
Other Amortization
2.582.281.210.490.950.2
Loss (Gain) From Sale of Assets
-0.47-0.470.6-00.35-0.05
Asset Writedown & Restructuring Costs
5.950.030.553-1.98
Loss (Gain) From Sale of Investments
-2.65-2.65-1.67-15.64-3.48-7.63
Provision & Write-off of Bad Debts
7.1411.683.9212.9811.877.82
Other Operating Activities
82.5824.6351.1641.529.9719.65
Change in Accounts Receivable
-47.54-47.54-40.88-36.65-110.01-91.03
Change in Inventory
-43.94-43.9413.84-35.62-19.16-33.19
Change in Accounts Payable
-9.19-9.19-6.4633.1551.0310.24
Operating Cash Flow
174.41113.95195.41153.5995.3189.51
Operating Cash Flow Growth
5.09%-41.69%27.22%61.16%6.47%-48.26%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-75.54-80.01-104.72-215.64-342.02-493.58
Sale of Property, Plant & Equipment
-0.020.262.080.930.110.11
Cash Acquisitions
-3.77-3.77-18.36-16.84-0.91-45.96
Divestitures
2.462.460.41-0.2--
Investment in Securities
-5.1-16.6165.43-75.81-103.12-75.43
Other Investing Activities
27.6223.0912.7110.9117.778.13
Investing Cash Flow
-54.35-74.59-42.46-296.66-428.17-606.73

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-752.99842.68661.27489.55360
Total Debt Issued
686.44752.99842.68661.27489.55360
Long-Term Debt Repaid
--716.04-915.25-461.16-203.7-192.44
Total Debt Repaid
-776.27-716.04-915.25-461.16-203.7-192.44
Net Debt Issued (Repaid)
-89.8436.95-72.57200.11285.85167.56
Issuance of Common Stock
---7.764.74498.82
Common Dividends Paid
-41.47-43.01-55.23-39.77-52.77-37.79
Other Financing Activities
-40.57-31.4-13.67-11.74-10.1-48.03
Financing Cash Flow
-171.87-37.46-141.47156.36227.72580.56

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.18-0.180.130.731.07-1.47
Net Cash Flow
-51.991.7111.6114.03-104.0761.87

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
98.8733.9490.69-62.05-246.72-404.06
Free Cash Flow Growth
22.80%-62.58%----
Free Cash Flow Margin
6.83%2.48%6.87%-5.18%-21.21%-35.11%
Free Cash Flow Per Share
0.400.140.36-0.25-0.95-1.65
Levered Free Cash Flow
21.84-29.1610.1420.05-241.42-418.19
Unlevered Free Cash Flow
25.33-17.9123.8229.56-236.94-416.86

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
101.2105.1983.8480.8244.6258.15
Change in Working Capital
-107.32-107.32-33.99-43.24-79.9-116.74